Evogene (Israel) Buy Hold or Sell Recommendation
| EVGN Stock | ILA 241.10 15.70 6.11% |
Assuming the 90 days trading horizon and your complete indifference towards market risk, our recommendation regarding Evogene is 'Cautious Hold'. Macroaxis provides Evogene buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Evogene positions. The advice algorithm takes into account all of Evogene's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Evogene's buy or sell advice are summarized below:
Real Value 227.28 | Hype Value 241.1 | Market Value 241.1 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Evogene given historical horizon and risk tolerance towards Evogene. When Macroaxis issues a 'buy' or 'sell' recommendation for Evogene, the advice is generated through an automated system that utilizes algorithms and statistical models.
Evogene |
Execute Evogene Buy or Sell Advice
The Evogene recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Evogene. Macroaxis does not own or have any residual interests in Evogene or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Evogene's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Moves totally opposite to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Evogene Trading Alerts and Improvement Suggestions
| Evogene generated a negative expected return over the last 90 days | |
| Evogene has high historical volatility and very poor performance | |
| The company reported the revenue of 930 K. Net Loss for the year was (27.79 M) with profit before overhead, payroll, taxes, and interest of 163 K. | |
| Evogene has accumulated about 65.36 M in cash with (24.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.61. |
Evogene Returns Distribution Density
The distribution of Evogene's historical returns is an attempt to chart the uncertainty of Evogene's future price movements. The chart of the probability distribution of Evogene daily returns describes the distribution of returns around its average expected value. We use Evogene price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Evogene returns is essential to provide solid investment advice for Evogene.
| Mean Return | -0.38 | Value At Risk | -5.57 | Potential Upside | 3.47 | Standard Deviation | 4.16 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Evogene historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Evogene Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Evogene or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Evogene's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Evogene stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.3 | |
β | Beta against NYSE Composite | -1.23 | |
σ | Overall volatility | 4.16 | |
Ir | Information ratio | -0.11 |
Evogene Volatility Alert
Evogene exhibits very low volatility with skewness of 2.1 and kurtosis of 7.33. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Evogene's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Evogene's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Evogene Fundamentals Vs Peers
Comparing Evogene's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Evogene's direct or indirect competition across all of the common fundamentals between Evogene and the related equities. This way, we can detect undervalued stocks with similar characteristics as Evogene or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Evogene's fundamental indicators could also be used in its relative valuation, which is a method of valuing Evogene by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Evogene to competition |
| Fundamentals | Evogene | Peer Average |
| Return On Equity | -0.63 | -0.31 |
| Return On Asset | -0.28 | -0.14 |
| Operating Margin | (24.02) % | (5.51) % |
| Current Valuation | 8.8 M | 16.62 B |
| Shares Outstanding | 41.22 M | 571.82 M |
| Shares Owned By Insiders | 3.58 % | 10.09 % |
| Shares Owned By Institutions | 3.37 % | 39.21 % |
| Price To Book | 0.93 X | 9.51 X |
| Price To Sales | 73.01 X | 11.42 X |
| Revenue | 930 K | 9.43 B |
| Gross Profit | 163 K | 27.38 B |
| EBITDA | (26.78 M) | 3.9 B |
| Net Income | (27.79 M) | 570.98 M |
| Cash And Equivalents | 65.36 M | 2.7 B |
| Cash Per Share | 1.61 X | 5.01 X |
| Total Debt | 2.39 M | 5.32 B |
| Debt To Equity | 0.03 % | 48.70 % |
| Current Ratio | 12.74 X | 2.16 X |
| Book Value Per Share | 0.74 X | 1.93 K |
| Cash Flow From Operations | (24.72 M) | 971.22 M |
| Earnings Per Share | (0.72) X | 3.12 X |
| Target Price | 5.0 | |
| Number Of Employees | 133 | 18.84 K |
| Beta | 0.9 | -0.15 |
| Market Capitalization | 121.59 M | 19.03 B |
| Total Asset | 76.3 M | 29.47 B |
| Retained Earnings | (90 M) | 9.33 B |
| Working Capital | 89 M | 1.48 B |
| Current Asset | 95 M | 9.34 B |
| Current Liabilities | 6 M | 7.9 B |
| Z Score | 29.8 | 8.72 |
| Net Asset | 76.3 M |
Evogene Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Evogene . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.0545 | |||
| Daily Balance Of Power | (1.13) | |||
| Rate Of Daily Change | 0.94 | |||
| Day Median Price | 248.05 | |||
| Day Typical Price | 245.73 | |||
| Market Facilitation Index | 13.9 | |||
| Price Action Indicator | (14.80) | |||
| Period Momentum Indicator | (15.70) |
About Evogene Buy or Sell Advice
When is the right time to buy or sell Evogene? Buying financial instruments such as Evogene Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Evogene in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Iron Thematic Idea Now
Iron
Companies involved in production of steel and iron. The Iron theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Iron Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Evogene Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Evogene Stock refer to our How to Trade Evogene Stock guide.You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Complementary Tools for Evogene Stock analysis
When running Evogene's price analysis, check to measure Evogene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evogene is operating at the current time. Most of Evogene's value examination focuses on studying past and present price action to predict the probability of Evogene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evogene's price. Additionally, you may evaluate how the addition of Evogene to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |